Fox Chase Cancer Center and the Lewis Katz School of Medicine Announce American Cancer Society Institutional Research Grant Winners

December 22, 2017

PHILADELPHIA (December 22, 2017) – Fox Chase Cancer Center and the Lewis Katz School of Medicine are pleased to announce the winners of its American Cancer Society Institutional Research Grant (IRG) Pilot Project Competition for Junior Investigators. The competition was open to eligible junior faculty at Fox Chase and the Lewis Katz School of Medicine at Temple University.

This year’s awardees are Sergei Grivennikov, PhD, assistant professor at Fox Chase, Rongsheng (Ross) Wang, PhD, assistant professor at the Lewis Katz School of Medicine at Temple University, and Elias Obeid, MD, MPH, assistant professor, at Fox Chase.

Grivennikov’s winning project was, “The Role of Interleukin 17RB Signaling in Colitis Associated Colon Cancer.”

Wang earned the award for, “Novel Protein Agents for Image-Guided Cancer Therapy.”

Obeid received a Special Interest Award for his proposal, “Exploring the Prostate Cancer Genome in Men of African Descent.” The Special Interest Award provides support for psychosocial and behavioral research, health policy or health services research, cancer in the poor and medically underserved, and childhood cancer.  

The purpose of the IRG is to provide seed money for the initiation of promising new projects by newer investigators so they can leverage preliminary results that enable them to compete successfully for national research grants. Each award provides funding of $60,000 over two years.

“We thank the American Cancer Society for supporting our researchers at the early stage of their careers,” said Jonathan Chernoff, MD, PhD, senior vice president and chief scientific officer at Fox Chase. Chernoff serves as principal investigator of the American Cancer Society grant and chair of the review committee for the competition.


The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.


For more information, call 888-369-2427

Connect with Fox Chase